GlucoTrack, Inc. (GCTK) vs HCW Biologics Inc. (HCWB)
A side-by-side comparison of GlucoTrack, Inc. and HCW Biologics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GCTK
GlucoTrack, Inc.
$1.11HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
HCWB
HCW Biologics Inc.
$1.64HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — GCTK vs HCWB
growth of $100 · dividends reinvested · last 5yGCTK -100.0% (-92.5%/yr)HCWB -99.9% (-74.5%/yr)HCWB compounded faster over this window
Log scale — wide-divergence pair
GCTK HCWB
GCTK vs HCWB: by the numbers
- •GCTK is the larger company ($885939 vs $570131 market cap).
- •Both run net losses; GCTK's is the smaller (0.00% vs -73.22% net margin).
Metrics side by side
Valuation
| Metric | GCTK | HCWB |
|---|---|---|
| P/S ratio | N/A | 0.08 |
| P/B ratio | N/A | 0.08 |
Profitability
| Metric | GCTK | HCWB |
|---|---|---|
| Gross margin | 0.00% | 20.00% |
| Operating margin | 0.00% | -20757.65% |
| Net margin | 0.00% | -73.22% |
| ROE | N/A | -66.26% |
| ROIC | N/A | -41.92% |
Growth (annualized)
| Metric | GCTK | HCWB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -57.90% |
| Total return CAGR (5Y) | -92.60% | -69.71% |
Frequently asked
- How have GCTK and HCWB total returns compared?
- Over the past 5 years, GCTK delivered -92.60% and HCWB delivered -69.71% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.